These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35006518)

  • 1. Polypharmacy in elderly people.
    Dovjak P
    Wien Med Wochenschr; 2022 Apr; 172(5-6):109-113. PubMed ID: 35006518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
    van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
    Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
    Zidan A; Awaisu A
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Deprescribing of inappropriate medication in primary care].
    Høj K; Mygind A; Livbjerg S; Bro F
    Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
    Todd A; Jansen J; Colvin J; McLachlan AJ
    BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing in Older Adults With Cardiovascular Disease.
    Krishnaswami A; Steinman MA; Goyal P; Zullo AR; Anderson TS; Birtcher KK; Goodlin SJ; Maurer MS; Alexander KP; Rich MW; Tjia J;
    J Am Coll Cardiol; 2019 May; 73(20):2584-2595. PubMed ID: 31118153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark.
    Schiøtz ML; Frølich A; Jensen AK; Reuther L; Perrild H; Petersen TS; Kornholt J; Christensen MB
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00431. PubMed ID: 30386624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing in older people.
    O'Mahony MS; Parbhoo A
    Br J Hosp Med (Lond); 2020 Jan; 81(1):1-9. PubMed ID: 32003625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.
    Carollo M; Boccardi V; Crisafulli S; Conti V; Gnerre P; Miozzo S; Omodeo Salè E; Pieraccini F; Zamboni M; Marengoni A; Onder G; Trifirò G;
    Aging Clin Exp Res; 2024 Mar; 36(1):63. PubMed ID: 38459218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
    Kaminaga M; Komagamine J; Tatsumi S
    Sci Rep; 2021 Apr; 11(1):8898. PubMed ID: 33903645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Patient Preferences in Deprescribing.
    Holmes HM; Todd A
    Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
    Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B
    Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing in palliative patients with cancer: a concise review of tools and guidelines.
    van Merendonk LN; Crul M
    Support Care Cancer; 2022 Apr; 30(4):2933-2943. PubMed ID: 34617161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Prescribing: Polypharmacy and Deprescribing.
    McQuade BM; Campbell A
    FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy, the Elderly, and Deprescribing.
    Jetha S
    Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.